We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
thier treatment for Covid-19, could also be tailored for Covid-20, or 21 if new strains of the virus develop (which some scientist have predicted is possible now). This is very powerful statement from TILS. The CEO also said Covid-19 has caught them by surpise, and they have been very busy over the last 3 weeks. So how far are they?...it sounds like as soon as patent is accepted, they will be UK/USA hospitals and deliver the treatment to critically ill people, so there is some hope for them. Currently, 90% die when they get to this stage.
It looks like the CEO is personally enagaged with devopment/lobby for TILS Covid treatment, and has had direct experience from previous outbreaks. Only this time they have the goods 9the actula drug) in hand (drug technology was aquired in 2017 from a swiss co) for a different purpose, but fits in with Covid 100%, and hence they have made this their top business priority.
There are few other points I picked up, which i will try to hughlight later. Looks like like a home run from here. They are ahead of SNG which helps control breathing, where is TILS clears the actual infection in the lungs, therefore not only helping the lungs to consume oxygen but also reducing the spread of the virus cells that acually go on to kill other parts of the body (i.e. the organs).
Feeling very positive, and feel broker target will be met soon or later.
It had great run to 165p four weeks ago, and now the co has $10m cash, and has filed the patent (this has to be done first before they release their treatment - it is a must, and proves they are serious and ready to go!). Therefore, expect over £2 on patent acceptance/ approval, and over £4 as teh treat the first list of patients in the feild.
Nyct at 70p....was crazy weeks ago.....:) ..... $4+ yesterday. And that was a Covid test.....TILS is cure/ treatment. Indication that it has been used succesfully in China, and TILS treatment has a couple of distinct advantages overs others. Hence why TILS pushing forwad as they are. Happy to put the house on this, pps is still low, can't go much lower (limited), upside multi bags. and we love multi bags. :)
thier treatment for Covid-19, could also be tailored for Covid-20, or 21 if new strains develop. This is very powerful. The CEO also said Covid-19 has caught them by surpise, and the have been very busy over the last 3 weeks. So how far are they...it sounds like as soon as patent is accepted, they will be UK/USA hositals and delivery the treatment to critical ill people, so there is some hope.
It looks like the CEO is personally enagaged with devopment and lobby for Covid, and has had direct experience from previous outbreaks. Only this time they have goods in the hand (technology was aquired in 2017 from a swiss co) for different purpose, but fits in with Covid, and hence they have made this their top business priority.
There are few other points I picked up, which i will try to hughlight later. Looks like like home run here. They are ahead of SNG which helps control breathing, where is TILLS clears the actual infection in the longs, therefore not only helping to lungs to consume oxygen as well as reducing the spread of the virus cells that kills go to kill other part of the body (organs).
enough for today. feeling very positive, and feel broker target will be met soon or later.